R-Biopharm Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Private

  • Employees
  • 1,400

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 5

  • Investments
  • 13

R-Biopharm General Information

Description

Provider of diagnostic technologies and products designed intended for nutrition care and food analysis. The company provides quality control, analytical service, clinical diagnostics, and beer analysis, therefore enabling it to improve everyday life for many people and contribute to health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • An der neuen Bergstraße 17
  • 64297 Darmstadt
  • Germany
+49 06151
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • An der neuen Bergstraße 17
  • 64297 Darmstadt
  • Germany
+49 06151

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

R-Biopharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore R-Biopharm‘s full profile, request access.

Request a free trial

R-Biopharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of diagnostic technologies and products designed intended for nutrition care and food analysis. The company pro
Biotechnology
Darmstadt, Germany
1,400 As of 2025

Pullman, WA
 

Mountain View, CA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

R-Biopharm Competitors (17)

One of R-Biopharm’s 17 competitors is VMRD, a Corporation company based in Pullman, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VMRD Corporation Pullman, WA
Astra Biotech Corporation Mountain View, CA
Enzo Biochem Private Equity-Backed Farmingdale, NY
Organogenesis Holdings Pending Transaction (M&A) Canton, MA
Meridian Bioscience Private Equity-Backed Cincinnati, OH
You’re viewing 5 of 17 competitors. Get the full list »

R-Biopharm Patents

R-Biopharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3524983-A1 Method for quantification of total gluten from cereals in food samples Inactive 08-Feb-2018
AU-2019218334-A1 Method for the quantification of the total gluten content of grains in food samples Active 08-Feb-2018
AU-2019218334-B2 Method for the quantification of the total gluten content of grains in food samples Active 08-Feb-2018
EP-3749955-A1 Method for the quantification of the total gluten content of grains in food samples Pending 08-Feb-2018
US-20200400638-A1 Method for the quantification of the total gluten content of grains in food samples Pending 08-Feb-2018 G01N33/02
To view R-Biopharm’s complete patent history, request access »

R-Biopharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R-Biopharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore R-Biopharm‘s full profile, request access.

Request a free trial

R-Biopharm Investments & Acquisitions (13)

R-Biopharm’s most recent deal was a Buyout/LBO with AusDiagnostics. The deal was made on 07-Jun-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AusDiagnostics 07-Jun-2022 Buyout/LBO Diagnostic Equipment
GeneWake 29-Oct-2015 Buyout/LBO Biotechnology
PROGEN Biotechnik 08-Oct-2012 Buyout/LBO Biotechnology
BIOSERV Diagnostics 01-Jan-2012 Buyout/LBO Diagnostic Equipment
humatrix 25-Nov-2011 Buyout/LBO Biotechnology
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

R-Biopharm Exits (1)

R-Biopharm’s most recent exit was on 18-May-2010 from Zedira. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Zedira 18-May-2010 Completed
  • 2 buyers
To view R-Biopharm’s complete exits history, request access »

R-Biopharm Affiliates

Subsidiaries (17)

Name Industry Location Year Founded
Aprimeo Diagnostics Pfungstadt, Germany 2019
R-Biopharm Nederland Arnhem, Netherlands 2018
Wolfgang Mock Gross-Umstadt, Germany 2014
CoGAP Koln, Germany 2010
BIOAVID Diagnostics Darmstadt, Germany 2008
You’re viewing 5 of 17 affiliates. Get the full list.  »

R-Biopharm FAQs

  • When was R-Biopharm founded?

    R-Biopharm was founded in 1988.

  • Where is R-Biopharm headquartered?

    R-Biopharm is headquartered in Darmstadt, Germany.

  • What is the size of R-Biopharm?

    R-Biopharm has 1,400 total employees.

  • What industry is R-Biopharm in?

    R-Biopharm’s primary industry is Biotechnology.

  • Is R-Biopharm a private or public company?

    R-Biopharm is a Private company.

  • What is R-Biopharm’s current revenue?

    The current revenue for R-Biopharm is .

  • Who are R-Biopharm’s investors?

    Federal State of Hesse has invested in R-Biopharm.

  • Who are R-Biopharm’s competitors?

    VMRD, Astra Biotech, Enzo Biochem, Organogenesis Holdings, and Meridian Bioscience are some of the 17 competitors of R-Biopharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process